StockData
Sigyn Therapeutics, Inc. logo

Sigyn Therapeutics, Inc. (SIGY) stock

SIGYOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2025, quý kết thúc ngày Sep 30, 2025Last filing: 10-Q on Nov 14, 2025Score 0/30
$0.03+0.00 (0.00%)

Close on Oct 19, 2026Market cap $48.16KP/E –Yield –

Sigyn Therapeutics gross margin

Gross margin is gross profit as a percentage of revenue.

Sigyn Therapeutics's gross margin for the twelve months ending Sep 30, 2020 was 63.4%. For fiscal 2019 it was 75.1%, against 65.7% the year before. The highest annual figure on record is 75.1% in fiscal 2019.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2019Dec 31, 201975.1%+9.4
FY2018Dec 31, 201865.7%+21.5
FY2017Dec 31, 201744.2%−21.8
FY2015Dec 31, 201566.0%+24.5
FY2014Dec 31, 201441.5%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2020Sep 30, 202053.1%−20.8
Q1 FY2020Mar 31, 202065.2%−12.5
Q4 FY2019Dec 31, 201970.5%−15.5
Q3 FY2019Sep 30, 201975.0%−25.0
Q2 FY2019Jun 30, 201973.8%+15.7
Q1 FY2019Mar 31, 201977.7%+16.2
Q3 FY2018Sep 30, 201886.0%+28.8
Q2 FY2018Jun 30, 2018100.0%+28.3
Q1 FY2018Mar 31, 201858.2%–
Q3 FY2017Sep 30, 201761.5%–
Q2 FY2017Jun 30, 201757.2%–
Q1 FY2017Mar 31, 201771.7%–

More Sigyn Therapeutics figures

See a number that looks wrong?